Evidence map›Paper›PMID 33336175›Full record

ReviewWorld journal of otorhinolaryngology - head and neck surgery2020

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis.

Daniel B Spielman, Jonathan Overdevest, David A Gudis

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of otorhinolaryngology - head and neck surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Current Review of Comorbidities in Chronic Rhinosinusitis.Current allergy and asthma reports · 2024
    Review
  2. Use of nonsteroidal anti-inflammatory drugs and poor olfaction in women.International forum of allergy & rhinology · 2024
    Article
  3. Chronic Rhinosinusitis and COVID-19.The journal of allergy and clinical immunology. In practice · 2022
    Review
  4. AERD: Quo Vadis?World journal of otorhinolaryngology - head and neck surgery · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel B SpielmanDepartment of Otolaryngology - Head and Neck Surgery, Columbia University Medical Center, New York, NY, 10032, USA.
Jonathan OverdevestDepartment of Otolaryngology - Head and Neck Surgery, Columbia University Medical Center, New York, NY, 10032, USA.
David A GudisDepartment of Otolaryngology - Head and Neck Surgery, Columbia University Medical Center, New York, NY, 10032, USA.
Columbia University Irving Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.

Indexed as

AERDAspirin desensitizationAspirin exacerbated respiratory diseaseEndoscopic sinus surgeryhyposmiaNSAIDOlfactionSamter's Triad

Identifiers

PMID33336175
PMCPMC7729240
OpenAlexW3080373308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.